Visit megaphone.fm/adchoices Day 345 Essentials: Using Play to Rewire & Improve Your Brain In this Huberman Lab Essentials episode, I discuss why play is a powerful yet often overlooked tool for shaping the brain across the entire lifespan, not just during childhood
However, after losing weight, he stopped using the GLP-1 and told People that he quickly regained 20 pounds
This guide examines theoretical cagrilintide dosage protocols when combined with tirzepatide, potential synergies and risks, conservative vs aggressive dosing strategies, comparing this combination to proven alternatives (CagriSema, tirzepatide monotherapy), who might consider this experimental approach, and safer evidence-based options that deliver comparable results
Zepbound received FDA approval in November 2023 for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity
The drug is part of a group called GLP-1 receptor agonists
